Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis

AIM: Cystic fibrosis (CF) patients are at high risk of developing CF-related diabetes (CFRD). In non-CF patients, liver disease, specifically steatosis and non-alcoholic fatty liver disease (NAFLD), is strongly associated with type 2 diabetes. We compared glycemic status and metabolic profiles in CF...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Colomba, Johann, Netedu, Silvia R., Lehoux-Dubois, Catherine, Coriati, Adèle, Boudreau, Valérie, Tremblay, François, Cusi, Kenneth, Rabasa-Lhoret, Rémi, Leey, Julio A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6638946/
https://ncbi.nlm.nih.gov/pubmed/31318914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0219855
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky